{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T04:17:21Z","timestamp":1774412241567,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.prp.2022.153877","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:17:24Z","timestamp":1648779444000},"page":"153877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Relationship between the changes of positivity rate of HER2 expression and the diameter of invasive lesions in early breast cancer and its clinical significance"],"prefix":"10.1016","volume":"233","author":[{"given":"Dandan","family":"Han","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rongbo","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Yue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongqiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yueping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.prp.2022.153877_bib1","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1200\/JCO.2013.52.0858","article-title":"Distant invasive breast cancer recurrence risk in human epidermal growth factor receptor 2-positive T1a and T1b node-negative localized breast cancer diagnosed from 2000 to 2006: a cohort from an integrated health care delivery system","volume":"32","author":"Fehrenbacher","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2022.153877_bib2","first-page":"89","article-title":"HER2 gene protein assay is useful to determine HER2 status and evaluate HER2 heterogeneity in HER2 equivocal breast cancer","volume":"147","author":"Hou","year":"2017","journal-title":"Am. J. Clin. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2022.153877_bib3","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41379-020-00728-z","article-title":"Clinical significance of quantitative categorization of HER2 fluorescent in situ hybridization results in invasive breast cancer patients treated with HER2-targeted agents","volume":"34","author":"Alhamar","year":"2021","journal-title":"Mod. Pathol."},{"issue":"4","key":"10.1016\/j.prp.2022.153877_bib4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/jso.1100","article-title":"Breast cancer in the third millennium","volume":"77","author":"Cady","year":"2001","journal-title":"J. Surg. Oncol."},{"issue":"13","key":"10.1016\/j.prp.2022.153877_bib5","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1200\/JCO.2005.02.8035","article-title":"Prognosis and management of patients with node-negative invasive breast carcinoma that is 1 cm or smaller in size (stage 1; T1a,bN0M0): a review of the literature","volume":"24","author":"Hanrahan","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2022.153877_bib6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1006130911110","article-title":"Prognostic factors for patients with breast cancers 1 cm and smaller","volume":"51","author":"Chen","year":"1998","journal-title":"Breast Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.prp.2022.153877_bib7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0959-8049(95)00610-9","article-title":"Prognosis of patients with breast cancers up to 1 cm in diameter","volume":"32A","author":"Fentiman","year":"1996","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.prp.2022.153877_bib8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10549-016-3878-9","article-title":"The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer","volume":"158","author":"Van Ramshorst","year":"2016","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.prp.2022.153877_bib9","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/cam4.167","article-title":"HER2 overexpression a major risk factor for recurrence in pT1a-bN0M0 breast cancer: results from a French regional cohort","volume":"3","author":"Rouanet","year":"2014","journal-title":"Cancer Med."},{"key":"10.1016\/j.prp.2022.153877_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctrv.2015.11.010","article-title":"Prognostic risk factors for treatment decision in pT1a,b N0M0 HER2-positive breast cancers","volume":"43","author":"Musolino","year":"2016","journal-title":"Cancer Treat. Rev."},{"issue":"2","key":"10.1016\/j.prp.2022.153877_bib11","doi-asserted-by":"crossref","first-page":"e205","DOI":"10.1016\/j.jss.2009.07.030","article-title":"Significance of HER2 protein examination in ductal carcinoma in situ","volume":"167","author":"Horimoto","year":"2011","journal-title":"J. Surg. Res"},{"issue":"5","key":"10.1016\/j.prp.2022.153877_bib12","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1158\/1055-9965.EPI-08-1101","article-title":"HER-2\/neu overexpression as a predictor for the transition from in situ to invasive breast cancer","volume":"18","author":"Roses","year":"2009","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"10","key":"10.1016\/j.prp.2022.153877_bib13","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1245\/s10434-019-07556-9","article-title":"DCIS with microinvasion: is it in situ or invasive disease?","volume":"26","author":"Champion","year":"2019","journal-title":"Ann. Surg. Oncol."},{"issue":"39","key":"10.1016\/j.prp.2022.153877_bib14","doi-asserted-by":"crossref","first-page":"64182","DOI":"10.18632\/oncotarget.11639","article-title":"Biologic behavior and long-term outcomes of breast ductal carcinoma in situ with microinvasion","volume":"7","author":"Fang","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"10.1016\/j.prp.2022.153877_bib15","doi-asserted-by":"crossref","first-page":"3853","DOI":"10.1245\/s10434-015-4476-5","article-title":"The role of sentinel lymph node biopsy and factors associated with invasion in extensive DCIS of the breast treated by mastectomy: the cinnamome prospective multicenter study","volume":"22","author":"Tunon-de-Lara","year":"2015","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.prp.2022.153877_bib16","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1245\/s10434-012-2640-8","article-title":"Microinvasive breast cancer: ER, PR, and HER-2\/neu status and clinical outcomes after breast-conserving therapy or mastectomy","volume":"20","author":"Margalit","year":"2013","journal-title":"Ann. Surg. Oncol."},{"issue":"11","key":"10.1016\/j.prp.2022.153877_bib17","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1093\/annonc\/mdq786","article-title":"Coping with uncertainty: T1a,bN0M0 HER2-positive breast cancer, do we have a treatment threshold?","volume":"22","author":"Kelly","year":"2011","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.prp.2022.153877_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.prp.2010.08.005","article-title":"HER2-positive status is an independent predictor for coexisting invasion of ductal carcinoma in situ of the breast presenting extensive DCIS component","volume":"207","author":"Liao","year":"2011","journal-title":"Pathol. Res. Pr."},{"key":"10.1016\/j.prp.2022.153877_bib19","doi-asserted-by":"crossref","first-page":"42045","DOI":"10.1038\/srep42045","article-title":"The demographic features, clinicopathological characteristics and cancer-specific outcomes for patients with microinvasive breast cancer: A SEER database analysis","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.prp.2022.153877_bib20","first-page":"290","article-title":"Breast Cancer-major Changes in the American Joint Committee on Cancer","volume":"67","author":"Giuliano","year":"2017"},{"issue":"12","key":"10.1016\/j.prp.2022.153877_bib21","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1200\/JCO.19.02309","article-title":"Estrogen and progesterone receptor testing in breast cancer: ASCO\/CAP guideline update","volume":"38","author":"Allison","year":"2020","journal-title":"J. Clin. Oncol."},{"issue":"20","key":"10.1016\/j.prp.2022.153877_bib22","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists Clinical Practice Guideline Focused Update","volume":"36","author":"Wolff","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2022.153877_bib23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/annonc\/mdu450","article-title":"The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014","volume":"2","author":"Salgado","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.prp.2022.153877_bib24","article-title":"Fully convolutional networks for semantic segmentation","author":"Jonathan","year":"2015","journal-title":"Proc. IEEE Conf. Comput. Vis. Pattern Recognit."},{"key":"10.1016\/j.prp.2022.153877_bib25","doi-asserted-by":"crossref","unstructured":"Chaurasia, Abhishek and Eugenio CulurcielloLinknet: Exploiting encoder representations for efficient semantic segmentation 2017 IEEE Visual Communications and Image Processing (VCIP). IEEE, 2017.","DOI":"10.1109\/VCIP.2017.8305148"},{"issue":"5","key":"10.1016\/j.prp.2022.153877_bib26","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1109\/PROC.1979.11328","article-title":"Statistical and structural approaches to texture","volume":"67","author":"Haralick","year":"2005","journal-title":"Proc. IEEE"},{"issue":"10","key":"10.1016\/j.prp.2022.153877_bib27","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1136\/jclinpath-2015-203506","article-title":"Two progressive pathways of microinvasive carcinoma: low-grade luminal pathway and high-grade HER2 pathway based on high tumour-infiltrating lymphocytes","volume":"69","author":"Morita","year":"2016","journal-title":"J. Clin. Pathol."},{"issue":"12","key":"10.1016\/j.prp.2022.153877_bib28","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1002\/(SICI)1097-0142(19980615)82:12<2382::AID-CNCR12>3.0.CO;2-L","article-title":"Mammary ductal carcinoma in situ with microinvasion","volume":"82","author":"Silver","year":"1998","journal-title":"Cancer."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822001200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033822001200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:36:19Z","timestamp":1774409779000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033822001200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":28,"alternative-id":["S0344033822001200"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2022.153877","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between the changes of positivity rate of HER2 expression and the diameter of invasive lesions in early breast cancer and its clinical significance","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2022.153877","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153877"}}